ADMA Biologics ADMA Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
Based on trailing twelve months.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's return on invested capital?
- ADMA Biologics (ADMA) reported return on invested capital of 44.8% in Q1 2026.
- How has ADMA Biologics's return on invested capital changed year-over-year?
- ADMA Biologics's return on invested capital decreased by 36.6% year-over-year, from 70.7% to 44.8%.
- What is the long-term trend for ADMA Biologics's return on invested capital?
- Over 5 years (2020 to 2025), ADMA Biologics's return on invested capital has grown at a -17.2% compound annual growth rate (CAGR), from -99% to 38.6%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.